Simplification Therapy with Once‐Daily Emtricitabine, Didanosine, and Efavirenz in HIV‐1–Infected Adults with Viral Suppression Receiving a Protease Inhibitor–Based Regimen: A Randomized Trial - Concepedia

Concepedia

Publication | Open Access

Simplification Therapy with Once‐Daily Emtricitabine, Didanosine, and Efavirenz in HIV‐1–Infected Adults with Viral Suppression Receiving a Protease Inhibitor–Based Regimen: A Randomized Trial

DOI Full Paper Access

68

Citations

25

References

2005

Year

Jean‐Michel Molina, Valérie Journot, Laurence Morand‐Joubert, Patrick Yéni, Willy Rozenbaum, Corinne Rancinan, Sandra Fournier, Philippe Morlat, Pierre Palmer, B. Dupont,

The Journal of Infectious Diseases

Abstract

Substituting a convenient once-daily combination of emtricitabine, didanosine, and efavirenz for a PI-based regimen was well tolerated and associated with sustained virologic suppression.

References

	Year	Citations

Page 1